Tirzepatide: A turning point in obesity related heart failure with preserved ejection fraction?

Goraya R, Saeed AB

Open source

DOI
10.47391/jpma.32630
Published
2026 Jun
Container
JPMA. The Journal of the Pakistan Medical Association
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.47391/jpma.32630,
  title = {Tirzepatide: A turning point in obesity related heart failure with preserved ejection fraction?},
  author = {Goraya R and Saeed AB},
  year = {2026},
  journal = {JPMA. The Journal of the Pakistan Medical Association},
  doi = {10.47391/jpma.32630},
  url = {https://doi.org/10.47391/jpma.32630}
}

RIS

TY  - JOUR
TI  - Tirzepatide: A turning point in obesity related heart failure with preserved ejection fraction?
AU  - Goraya R
AU  - Saeed AB
PY  - 2026
JO  - JPMA. The Journal of the Pakistan Medical Association
DO  - 10.47391/jpma.32630
UR  - https://doi.org/10.47391/jpma.32630
ER  - 

APA

R, G., & AB, S. (2026). Tirzepatide: A turning point in obesity related heart failure with preserved ejection fraction?. JPMA. The Journal of the Pakistan Medical Association. https://doi.org/10.47391/jpma.32630

Source records